Use of prostate-specific antigen progression (PSA-P) to predict overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): Data from S9346 and S9916
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. H. Hussain, B. Goldman, C. M. Tangen, C. S. Higano, D. P. Petrylak, E. D. Crawford
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2274512012
